Charissa Y Chang
Affiliation: Mount Sinai School of Medicine
- Review article: drug hepatotoxicityC Y Chang
The Division of Liver Diseases, Department of Internal Medicine, The Mount Sinai School of Medicine, New York, NY 10029 6574, USA
Aliment Pharmacol Ther 25:1135-51. 2007..Drug toxicity is the leading cause of acute liver failure in the United States. Further understanding of hepatotoxicity is becoming increasingly important as more drugs come to market...
- Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuriaCharissa Y Chang
Recanati Miller Transplant Institute, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, NY, USA
Liver Transpl 13:1532-7. 2007....
- Patient with hepatitis B and alcoholic liver disease before and after liver transplantationStephen C Ward
The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York 10029, USA
Semin Liver Dis 29:233-7. 2009..We discuss the interaction of alcoholic liver disease and hepatitis B virus in the development of cirrhosis and hepatocellular carcinoma, as well as the role of liver transplantation in these patients...
- Molecular approaches to treatment of hepatocellular carcinomaAnja Lachenmayer
Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, New York, USA
Dig Liver Dis 42:S264-72. 2010..In this article we review the current knowledge of the molecular pathogenesis of HCC and provide an overview of molecular targeted therapies in the management of HCC...
- A patient with chronic hepatitis B and regression of fibrosis during treatmentCharissa Y Chang
Division of Liver Diseases, Recanati Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NY 10001, USA
Semin Liver Dis 30:296-301. 2010..Lengthy antiviral treatment can achieve resorption of excess fibrous tissue, even in patients with marked fibrosis...
- Therapy of NAFLD: antioxidants and cytoprotective agentsCharissa Y Chang
Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA 22908-0708, USA
J Clin Gastroenterol 40:S51-60. 2006..Particular promise may exist in the use of these agents in combination therapy with ones that target other aspects in the pathogenesis of NAFLD, such as insulin-sensitizing agents...